Clinical Trials Browser

Phase 1 × Lymphoma, T-Cell, Peripheral × obinutuzumab × Clear all

NCT01644253 2021-05-20

Phase 1b Safety and Efficacy Study of TRU-016

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Peripheral